Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.91
+0.01 (0.14%)
Mar 24, 2026, 4:00 PM EDT - Market closed

Journey Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-8.66-14.67-3.85-29.63-43.995.28
Depreciation & Amortization
4.263.523.864.372.560.09
Stock-Based Compensation
5.896.12.614.432.47-
Other Adjustments
-0.04-0.34.291.1222.081.83
Change in Receivables
-6.844.4812.55-5.380.77-5.02
Changes in Inventories
-0.03-4.233.951.74-8.42-0.65
Changes in Accounts Payable
-3.78-2.1-18.4214.3420.39-0.15
Changes in Accrued Expenses
5.28-2.540.82-3.461.242.39
Changes in Income Taxes Payable
0.070.010.020.03-0.092.19
Changes in Other Operating Activities
-0.250.62-0.58-1.140.87-1.07
Operating Cash Flow
-4.1-9.135.24-13.53-2.185.13
Operating Cash Flow Growth
------43.09%
Purchases of Intangible Assets
--15-5-20-10-1.2
Investing Cash Flow
--15-5-20-10-1.2
Short-Term Debt Issued
--2857-
Short-Term Debt Repaid
---30.95-2.86-6.19-
Net Short-Term Debt Issued (Repaid)
---2.952.140.81-
Long-Term Debt Issued
5.05101519.769.54-
Long-Term Debt Repaid
-1.25-1.25-21-5-5.3-0.5
Net Long-Term Debt Issued (Repaid)
3.88.75-614.764.24-0.5
Issuance of Common Stock
19.888.294.620.1432.540.01
Net Common Stock Issued (Repurchased)
19.888.294.620.1432.540.01
Issuance of Preferred Stock
----18.97-
Net Preferred Stock Issued (Repurchased)
----18.97-
Other Financing Activities
-0.13-0.05-0.47-0.59-3.55-
Financing Cash Flow
21.4216.99-4.816.4653.02-0.49
Net Cash Flow
2.49-7.13-4.56-17.0840.843.45
Free Cash Flow
-6.16-9.135.24-13.53-2.185.13
Free Cash Flow Growth
------43.09%
FCF Margin
-10.37%-16.26%6.62%-18.37%-3.45%11.52%
Free Cash Flow Per Share
-0.27-0.450.29-0.77-0.190.47
Levered Free Cash Flow
0.68-10.65-23.153.15-22.417.58
Unlevered Free Cash Flow
-0.03-18.46-12.55-11.7-19.698.6
Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q